Description
NSTEMI Decide is a decision aid tool for patients ages 75 years and older considering cardiac catheterization as treatment for a heart attack. The app includes language translation (English or Spanish) and a language selection option before viewing health information. A Mehran Score calculator gives the user the ability to select and input health options to view their CIN Risk Scores. The app includes large images with zoom, scroll, and navigation, as well as links to external data sources.
Disclaimer:
This application is intended to facilitate discussion between patients and healthcare professionals. It is not intended as a substitute for professional medical judgment, diagnosis, or treatment. It should not be used by patients without direct consultation with, and supervision by, their healthcare provider.
Hide
Show More...
Disclaimer:
This application is intended to facilitate discussion between patients and healthcare professionals. It is not intended as a substitute for professional medical judgment, diagnosis, or treatment. It should not be used by patients without direct consultation with, and supervision by, their healthcare provider.
Screenshots
NSTEMI Decide FAQ
-
Is NSTEMI Decide free?
Yes, NSTEMI Decide is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is NSTEMI Decide legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does NSTEMI Decide cost?
NSTEMI Decide is free.
-
What is NSTEMI Decide revenue?
To get estimated revenue of NSTEMI Decide app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Mexico yet.
Ratings History
NSTEMI Decide Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
NSTEMI Decide Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
AI in Clinical Cardiology
|
View
|
View
|
0
|
|
1 year ago | |
TCC Cardiology Consultants
|
View
|
View
|
0
|
|
2 years ago | |
Cardiology Clinical Questions.
Best Point-of-Care Q&A Guide
|
View
|
View
|
0
|
|
1 year ago | |
Case Files Geriatrics, 1e
|
View
|
View
|
0
|
|
2 months ago | |
Swanton's Cardiology
Concise Clinical Guide
|
View
|
View
|
0
|
|
11 months ago | |
CURRENT Dx Tx Cardiology
Diagnosis Treatment Heart
|
View
|
View
|
0
|
|
3 weeks ago | |
CathSource
|
View
|
View
|
0
|
|
8 years ago | |
Inside Vascular Interventions
|
View
|
View
|
0
|
|
2 years ago | |
CIT Europe Device Guide
Cardiac Interventions Today EU
|
View
|
View
|
0
|
|
3 years ago | |
Echo Calculate
|
View
|
View
|
0
|
|
10 months ago |
NSTEMI Decide Installs
Last 30 days
NSTEMI Decide Revenue
Last 30 daysNSTEMI Decide Revenue and Downloads
Gain valuable insights into NSTEMI Decide performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- John Dodson
- Languages
- Spanish, English
- Recent release
- 1.2 (4 years ago )
- Released on
- May 29, 2020 (4 years ago )
- Also available in
- United States, Pakistan, Italy, Japan, South Korea, Kuwait, Kazakhstan, Lebanon, Mexico, Malaysia, Nigeria, Netherlands, Norway, Nepal, New Zealand, Peru, Philippines, India, Poland, Portugal, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Türkiye, Taiwan, Ukraine, Vietnam, South Africa, Dominican Republic, Argentina, Austria, Australia, Azerbaijan, Brazil, Belarus, Canada, Switzerland, Chile, China, Colombia, Czechia, Germany, Denmark, United Arab Emirates, Algeria, Ecuador, Estonia, Egypt, Spain, Finland, France, United Kingdom, Greece, Hong Kong SAR China, Hungary, Indonesia, Ireland, Israel
- Last Updated
- 1 month ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.